References
- Mommsen S, Aagaard J, Sell A. Presenting symptoms, treatment delay and survival in bladder cancer. Scand J Urol Nephrol 1983; 17: 163–7
- Boman H, Hedelin H, Jacobsson S, Holmäng S. Newly diagnosed bladder cancer: the relationship of initial symptoms, degree of microhematuria and tumor marker status. J Urol 2002; 168: 1955–9
- Malmström PU. Time to abandon testing for microscopic haematuria in adults?. Br Med J 2003; 326: 813–5
- Pompeius R, Fex G, Mattiasson I, Malmkvist I, Trell E, Laurell P. Hematuriscreening i yngre åldrar ger dåligt utbyte i förhållande till kostnaden. Läkartidningen 1984; 84: 545–7
- Holmquist B, Jacobsson K, Nilsson J, Ohlsson O, Thysell H, Winberg A. Oriktad hematuriscreening bör undvikas i den öppna vården. Läkartidningen 1984; 82: 548–51
- Messing EM, Young TB, Hunt VB, Roecker EB, Vaillancourt AM, Hisgren WJ, et al. Home screening for hematuria: results of a multiclinic study. J Urol 1992; 148: 289–92
- Britton JP, Dowell AC, Whelan P, Harris CM. A community study of bladder cancer screening by the detection of occult urinary bleeding. J Urol 1992; 148: 788–90
- Boman H, Hedelin H, Holmäng S. Four bladder tumour markers have a disappointingly low sensitivity for small size and low grade tumour recurrence. J Urol 2002; 167: 80–3
- Hedelin H, Holmäng S, Wiman L. Out-patient bladder cancer surgery; a means of reducing costs while maintaining quality. Nord Med 1997; 112: 48–51
- Jichlinski P, Guillou L, Karlsen SJ, Malmstrom PU, Jocham D, Brennhovd B, et al. Hexyl aminolevulinate fluorescence cystoscopy: new diagnostic tool for photodiagnosis of superficial bladder cancer—a multicenter study. J Urol 2003; 170: 226–9
- Barry MJ, Fowler FJ, O'Leary MP, Bruskewitz RC, Holtgrewe HL, Mebust WK, et al. The American Urological Association symptom index for benign prostatic hyperplasia. J Urol 1992; 148: 1549–57
- Ezz El Din K, Koch WF, de Wildt MJ, Debruyne FM, de la Rosette JJ. The predictive value of microscopic haematuria in patients with lower urinary tract symptoms and benign prostatic hyperplasia. Eur Urol 1996; 30: 409–13
- Mohr DN, Offord KP, Owen RA, Melton LJ 3rd. Asymptomatic microhematuria and urologic disease. A population-based study. JAMA 1986; 256: 224–9
- Hiatt RA, Ordoñez JD. Dipstick urinalysis screening asymptomatic microhematuria, and subsequent urological cancers in a population-based sample. Cancer Epidemiol Biomarkers Prev 1994; 3: 439–43